Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease.
Fiche publication
Date publication
août 2017
Journal
Inflammatory bowel diseases
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Buisson A, Gonzalez F, Poullenot F, Nancey S, Sollellis E, Fumery M, Pariente B, Flamant M, Trang-Poisson C, Bonnaud G, Mathieu S, Thevenin A, Duruy M, Filippi J, Lʼhopital F, Luneau F, Michalet V, Genès J, Achim A, Cruzille E, Bommelaer G, Laharie D, Peyrin-Biroulet L, Pereira B, Nachury M, Bouguen G,
Lien Pubmed
Résumé
Objective control of intestinal inflammation during inflammatory bowel disease (IBD) is becoming the main driver for medical treatment. However, the monitoring tools-related burden remains poorly investigated. We aimed to evaluate their comparative acceptability and utility according to patients with IBD.
Mots clés
Adult, Biomarkers, analysis, Capsule Endoscopy, Colonoscopy, Female, Follow-Up Studies, Humans, Inflammatory Bowel Diseases, diagnosis, Male, Perception, Prognosis, Prospective Studies, Surveys and Questionnaires, Ultrasonography
Référence
Inflamm. Bowel Dis.. 2017 08;23(8):1425-1433